Skip to main content
. 2020 Aug 28;10(8):87. doi: 10.1038/s41408-020-00353-8

Table 2.

Disease response during follow-up.

Pre-transplant (n = 44) Day + 100 post ASCT (n = 46) Best response (n = 46)
CR or better 9 (20%) 27 (59%) 34 (74%)
VGPR 14 (32%) 13 (28%) 6 (13%)
PR 15 (34%) 5 (11%) 5 (11%)
Stable disease 6 (14%) 1 (2%) 1 (2%)